» Articles » PMID: 33725319

MiR-124 and Small Molecules Synergistically Regulate the Generation of Neuronal Cells from Rat Cortical Reactive Astrocytes

Overview
Journal Mol Neurobiol
Date 2021 Mar 16
PMID 33725319
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Irreversible neuron loss caused by central nervous system injuries usually leads to persistent neurological dysfunction. Reactive astrocytes, because of their high proliferative capacity, proximity to neuronal lineage, and significant involvement in glial scarring, are ideal starting cells for neuronal regeneration. Having previously identified several small molecules as important regulators of astrocyte-to-neuron reprogramming, we established herein that miR-124, ruxolitinib, SB203580, and forskolin could co-regulate rat cortical reactive astrocyte-to-neuron conversion. The induced cells had reduced astroglial properties, displayed typical neuronal morphologies, and expressed neuronal markers, reflecting 25.9% of cholinergic neurons and 22.3% of glutamatergic neurons. Gene analysis revealed that induced neuron gene expression patterns were more similar to that of primary neurons than of initial reactive astrocytes. On the molecular level, miR-124-driven neuronal differentiation of reactive astrocytes was via targeting of the SOX9-NFIA-HES1 axis to inhibit HES1 expression. In conclusion, we present a novel approach to inducing endogenous rat cortical reactive astrocytes into neurons through co-regulation involving miR-124 and three small molecules. Thus, our research has potential implications for inhibiting glial scar formation and promoting neuronal regeneration after central nervous system injury or disease.

Citing Articles

Circular RNA HIPK2 Promotes A1 Astrocyte Activation after Spinal Cord Injury through Autophagy and Endoplasmic Reticulum Stress by Modulating miR-124-3p-Mediated Smad2 Repression.

Yang J, Dong J, Li H, Gong Z, Wang B, Du K ACS Omega. 2024; 9(1):781-797.

PMID: 38222662 PMC: 10785321. DOI: 10.1021/acsomega.3c06679.


A promise for neuronal repair: reprogramming astrocytes into neurons in vivo.

Huang L, Lai X, Liang X, Chen J, Yang Y, Xu W Biosci Rep. 2024; 44(1).

PMID: 38175538 PMC: 10830445. DOI: 10.1042/BSR20231717.


Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges.

Chen J, Huang L, Yang Y, Xu W, Qin Q, Qin R Brain Sci. 2023; 13(3).

PMID: 36979334 PMC: 10046178. DOI: 10.3390/brainsci13030524.


Ginsenoside Rg1 promotes astrocyte-to-neuron transdifferentiation in rat and its possible mechanism.

Shen K, Wu D, Sun B, Zhu Y, Wang H, Zou W CNS Neurosci Ther. 2022; 29(1):256-269.

PMID: 36352836 PMC: 9804042. DOI: 10.1111/cns.14000.


Astrocyte-Derived Neuronal Transdifferentiation as a Therapy for Ischemic Stroke: Advances and Challenges.

Gong S, Shao H, Cai X, Zhu J Brain Sci. 2022; 12(9).

PMID: 36138912 PMC: 9497100. DOI: 10.3390/brainsci12091175.


References
1.
Ouyang W, Yan Q, Zhang Y, Fan Z . Moderate injury in motor-sensory cortex causes behavioral deficits accompanied by electrophysiological changes in mice adulthood. PLoS One. 2017; 12(2):e0171976. PMC: 5308857. DOI: 10.1371/journal.pone.0171976. View

2.
Okada S, Hara M, Kobayakawa K, Matsumoto Y, Nakashima Y . Astrocyte reactivity and astrogliosis after spinal cord injury. Neurosci Res. 2017; 126:39-43. DOI: 10.1016/j.neures.2017.10.004. View

3.
Burda J, Sofroniew M . Reactive gliosis and the multicellular response to CNS damage and disease. Neuron. 2014; 81(2):229-48. PMC: 3984950. DOI: 10.1016/j.neuron.2013.12.034. View

4.
Wang H, Song G, Chuang H, Chiu C, Abdelmaksoud A, Ye Y . Portrait of glial scar in neurological diseases. Int J Immunopathol Pharmacol. 2018; 31:2058738418801406. PMC: 6187421. DOI: 10.1177/2058738418801406. View

5.
Moeendarbary E, Weber I, Sheridan G, Koser D, Soleman S, Haenzi B . The soft mechanical signature of glial scars in the central nervous system. Nat Commun. 2017; 8:14787. PMC: 5364386. DOI: 10.1038/ncomms14787. View